Avenue Therapeutics, Inc.

Ownership Transactions Reported by 12 Insiders

Symbol
ATXI on OTC
Industry
Pharmaceutical Preparations
Location
1111 Kane Concourse, Suite 301, Bay Harbor Islands, FL

Insiders trading volume in the past year

Avenue Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fortress Biotech, Inc. 10%+ Owner $657K Mar 31, 2025
Robert Davidow 10%+ Owner $171K Dec 11, 2023
Lucy Lu President, CEO, Director $105K Dec 17, 2021
Alexandra MacLean Chief Executive Officer, Director $23.8K Sep 23, 2024
Joseph Vazzano Chief Financial Officer $23.2K Dec 17, 2021
David Jin Interim PFO and COO $9.1K Sep 23, 2024
Jay D. Kranzler Director $1.25K -$137 -9.86% Nov 5, 2024
Neil Herskowitz Director $194 -$46 -19.2% Dec 2, 2024
Curtis Gale Oltmans Director Sep 23, 2024
Lindsay A. Md Rosenwald Director Sep 23, 2024
InvaGen Pharmaceuticals, Inc. 10%+ Owner Oct 11, 2022
Faith L. Charles Director Sep 23, 2024

Recent Insider Transactions by Companies or Individuals for Avenue Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.